Effect of Ginkgo biloba extract on lipopolysaccharide-induced anhedonic depressive-like behavior in male rats

Phytotherapy Research

Volumn 29, Issue 2, 2015, Pages 260-266

  Yeh, Kuei Ying ^a   Shou, Sing Siang ^a   Lin, Yi Xuan ^a   Chen, Chao Cin ^a   Chiang, Chen Yen ^a   Yeh, Chien Yu ^b  

^a HUNGKUANG UNIVERSITY   (Taiwan)

^b Chih Yung Senior High School   (Taiwan)

Author keywords

Anhedonia; EGb 761; Lipopolysaccharide; Rat; Sucrose preference test

Indexed keywords

DOPAMINE; GINKGO BILOBA EXTRACT; KAEMPFEROL; LIPOPOLYSACCHARIDE; QUERCETIN; SEROTONIN; SUCROSE; GINKGO BILOBA EXTRACT 761; PLANT EXTRACT;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BODY MASS; CONTROLLED STUDY; DEPRESSION; DOPAMINE BLOOD LEVEL; DRUG EFFICACY; EXPERIMENTAL BEHAVIORAL TEST; FLUID INTAKE; FOOD INTAKE; FORCED SWIM TEST; LIGHT DARK CYCLE; MAJOR DEPRESSION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PLANT LEAF; RAT; SEROTONIN BLOOD LEVEL; SUCROSE PREFERENCE TEST; SUGAR INTAKE; SYMPTOMATOLOGY; TAIL SUSPENSION TEST; ANIMAL; BODY WEIGHT; CHEMISTRY; DRINKING; DRUG EFFECTS; EATING; GINKGO BILOBA; RANDOMIZATION; WISTAR RAT;

ANIMALIA; GINKGO BILOBA; RATTUS;

ANIMALS; BODY WEIGHT; DEPRESSION; DOPAMINE; DRINKING; EATING; GINKGO BILOBA; LIPOPOLYSACCHARIDES; MALE; NUCLEUS ACCUMBENS; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEROTONIN;

EID: 84922709719     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5247     Document Type: Article

References (68)

1. Ahmad M, Saleem S, Ahmad AS, et al. 2005. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced Parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J Neurochem 93: 94-104.
2. Andrade L, Caraveo-Anduaga JJ, Berglund P, et al. 2003. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res 12: 3-21.
3. Bachmanov AA, Reed DR, Ninomiya Y, et al. 1997. Sucrose consumption in mice: major influence of two genetic loci affecting peripheral sensory responses. Mamm Genome 8: 545-548.
4. Bekris S, Antoniou K, Daskas S, Papadopoulou-Daifoti Z. 2005. Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behav Brain Res 161: 45-59.
5. Berridge KC. 2000. Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns. Neurosci Biobehav Rev 24: 173-198.
6. Bluthe RM, Bristow A, Lestage J, Imbs C, Dantzer R. 2001. Central injection of interleukin-13 potentiates LPS-induced sickness behavior in rats. Neuroreport 12: 3979-3983.
7. Bressan RA, Crippa JA. 2005. The role of dopamine in reward and pleasure behaviour-review of data from preclinical research. Acta Psychiatr Scand Suppl 14-21.
8. Cantu TG, Korek JS. 1988. Monoamine oxidase inhibitors and weight gain. Drug Intell Clin Pharm 22: 755-759.
9. Chaudhury D, Walsh JJ, Friedman AK, et al. 2013. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 493: 532-536.
10. De La Garza R, 2nd. 2005. Endotoxin- or pro-inflammatory cytokineinduced sickness behavior as an animal model of depression: focus on anhedonia. Neurosci Biobehav Rev 29: 761-770.
11. DeFeudis FV, Drieu K. 2000. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets 1: 25-58.
12. Di Chiara G. 2002. Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res 137: 75-114.
13. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL. 2010. A meta-analysis of cytokines in major depression. Biol Psychiatry 67: 446-457.
14. Eaton WW, Anthony JC, Gallo J, et al. 1997. Natural history of Diagnostic Interview Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry 54: 993-999.
15. Ekuni D, Firth JD, Nayer T, et al. 2009. Lipopolysaccharide-induced epithelial monoamine oxidase mediates alveolar bone loss in a rat chronic wound model. Am J Pathol 175: 1398-1409.
16. Frenois F, Moreau M, O 'Connor J, et al. 2007. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 32: 516-531.
17. Gietzen DW, Erecius LF, Rogers QR. 1997. Neurochemical changes after imbalanced diets suggest a brain circuit mediating anorectic responses to amino acid deficiency in rats. J Nutr 128: 771-781.
18. Hajnal A, Norgren R. 2001. Accumbens dopamine mechanisms in sucrose intake. Brain Res 904: 76-84.
19. Hatzigiakoumis DS, Martinotti G, Giannantonio MD, Janiri L. 2011. Anhedonia and substance dependence: clinical correlates and treatment options. Front Psychiatr 2: 10.
20. Henry CJ, Huang Y, Wynne A, et al. 2008. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation 5: 15.
21. Ji WW, Wang SY, Ma ZQ, et al. 2014. Effects of perillaldehyde on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration. Pharmacol Biochem Behav 116: 1-8.
22. Kalkunte SS, Singh AP, Chaves FC, et al . 2007. Antidepressant and antistress activity of GC-MS characterized lipophilic extracts of Ginkgo biloba leaves. Phytother Res 21: 1061-1065.
23. Kaster MP, Gadotti VM, Calixto JB, Santos AR, Rodrigues AL. 2012. Depressive-like behavior induced by tumor necrosis factor-alpha in mice. Neuropharmacology 62: 419-426.
24. Kentner AC, McLeod SA, Field EF, Pittman QJ. 2010. Sex-dependent effects of neonatal inflammation on adult inflammatory markers and behavior. Endocrinology 151: 2689-2699.
25. Kessler RC, Berglund P, Demler O, et al. 2003. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289: 3095-3105.
26. Levine AS, Kotz CM, Gosnell BA. 2003. Sugars: hedonic aspects, neuroregulation, and energy balance. Am J Clin Nutr 78: 834S-842S.
27. Lin YL, Lin SY, Wang S. 2012. Prenatal lipopolysaccharide exposure increases anxiety-like behaviors and enhances stressinduced corticosterone responses in adult rats. Brain Behav Immun 26: 459-468.
28. Liu Y, Qin L, Wilson B, et al. 2008. Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits. Neurotoxicology 29: 864-870.
29. Maletic V, Raison CL. 2009. Neurobiology of depression, fibromyalgia and neuropathic pain. Front Biosci 14: 5291-5338.
30. Martinez-Hernandez J, Lanuza E, Martinez-Garcia F. 2006. Selective dopaminergic lesions of the ventral tegmental area impair preference for sucrose but not for male sexual pheromones in female mice. Eur J Neurosci 24: 885-893.
31. Martin-Soelch C. 2009. Is depression associated with dysfunction of the central reward system? Biochem Soc Trans 37: 313-317.
32. Miller AH, Maletic V, Raison CL. 2009. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65: 732-741.
33. Muneoka K, Shirayama Y, Takigawa M, Shioda S. 2009. Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats. Neurochem Res 34: 542-555.
34. Muscat R, Papp M, Willner P. 1992. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology (Berl) 109: 433-438.
35. Nestler EJ, Carlezon WA, Jr. 2006. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59: 1151-1159.
36. Ohgi Y, Futamura T, Kikuchi T, Hashimoto K. 2013. Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration. Pharmacol Biochem Behav 103: 853-859.
37. Ossewaarde L, Verkes RJ, Hermans EJ, et al. 2011. Two-week administration of the combined serotonin-noradrenaline reuptake inhibitor duloxetine augments functioning of mesolimbic incentive processing circuits. Biol Psychiatry 70: 568-574.
38. Palkovits M. 1973. Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res 59: 449-450.
39. Papp M, Willner P, Muscat R. 1991. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berl) 104: 255-259.
40. Papp M, Willner P, Muscat R. 1993. Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia. Psychopharmacology (Berl) 110: 159-164.
41. Papp M, Klimek V, Willner P. 1994. Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology (Berl) 115: 441-446.
42. Patel A. 2013. Review: the role of inflammation in depression. Psychiatr Danub 25(Suppl 2): S216-S223.
43. Pitychoutis PM, Nakamura K, Tsonis PA, Papadopoulou-Daifoti Z. 2009. Neurochemical and behavioral alterations in an inflammatory model of depression: sex differences exposed. Neuroscience 159: 1216-1232.
44. Porsolt RD, Martin P, Lenegre A, Fromage S, Drieu K. 1990. Effects of an extract of Ginkgo Biloba (EGB 761) on "learned helplessness" and other models of stress in rodents. Pharmacol Biochem Behav 36: 963-971.
45. Rojas P, Rojas C, Ebadi M, Montes S, Monroy-Noyola A, Serrano-Garcia N. 2004. EGb761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity. Neurochem Res 29: 1417-1423.
46. Rojas P, Serrano-Garcia N, Mares-Samano JJ, Medina-Campos ON, Pedraza-Chaverri J, Ogren SO. 2008. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress. Eur J Neurosci 28: 41-50.
47. Rojas P, Serrano-Garcia N, Medina-Campos ON, Pedraza-Chaverri J, Ogren SO, Rojas C. 2011. Antidepressant-like effect of a Ginkgo biloba extract (EGb761) in the mouse forced swimming test: role of oxidative stress. Neurochem Int 59 : 628-636.
48. Roth-Deri I, Friedman A, Abraham L, et al. 2009. Antidepressant treatment facilitates dopamine release and drug seeking behavior in a genetic animal model of depression. Eur J Neurosci 30: 485-492.
49. Sah SP, Tirkey N, Kuhad A, Chopra K. 2011. Effect of quercetin on lipopolysaccharide induced-sickness behavior and oxidative stress in rats. Indian J Pharmacol 43: 192-196.
50. Sakakibara H, Ishida K, Grundmann O, et al. 2006. Antidepressant effect of extracts from Ginkgo biloba leaves in behavioral models. Biol Pharm Bull 29: 1767-1770.
51. Santiago RM, Barbieiro J, Lima MM, Dombrowski PA, Andreatini R, Vital MA. 2010. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine. Prog Neuropsychopharmacol Biol Psychiatry 34: 1104-1114.
52. Shibata R, Kameishi M, Kondoh T, Torii K. 2009. Bilateral dopaminergic lesions in the ventral tegmental area of rats influence sucrose intake, but not umami and amino acid intake. Physiol Behav 96: 667-674.
53. Shih JC, Chen K, RiddMJ. 1999. Role ofMAOAand B in neurotransmitter metabolism and behavior. Pol J Pharmacol 51: 25-29.
54. Shimura T, Kamada Y, Yamamoto T. 2002. Ventral tegmental lesions reduce overconsumption of normally preferred taste fluid in rats. Behav Brain Res 134: 123-130.
55. Singal A, Tirkey N, Pilkhwal S, Chopra K. 2006. Green tea (Camellia sinensis) extract ameliorates endotoxin induced sickness behavior and liver damage in rats. Phytother Res 20: 125-129.
56. Sloley BD, Urichuk LJ, Morley P, et al. 2000. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves. J Pharm Pharmacol 52: 451-459.
57. Stricker EM, Zigmond MJ. 1984. Brain catecholamines and the central control of food intake. Int J Obes 8(Suppl 1): 39-50.
58. Treadway MT, Zald DH. 2011. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev 35: 537-555.
59. Wadsworth TL, McDonald TL, Koop DR. 2001. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharideinduced signaling pathways involved in the release of tumor necrosis factor-alpha. Biochem Pharmacol 62: 963-974.
60. Wang GJ, Volkow ND, Logan J, et al. 2001. Brain dopamine and obesity. Lancet 357: 354-357.
61. Wang SH, Zhang ZJ, Guo YJ, Zhou H, Teng GJ, Chen BA. 2009. Anhedonia and activity deficits in rats: impact of post-stroke depression. J Psychopharmacol 23: 295-304.
62. Willner P, Lappas S, Cheeta S, Muscat R. 1994. Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole. Psychopharmacology (Berl) 115: 454-462.
63. Wise RA. 2006. Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci 361: 1149-1158.
64. Wise RA. 2008. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 14: 169-183.
65. Wise RA, Spindler J, deWit H, Gerberg GJ. 1978. Neurolepticinduced "anhedonia" in rats: pimozide blocks reward quality of food. Science 201: 262-264.
66. Yeh KY, Wu CH, Tai MY, Tsai YF. 2011. Ginkgo biloba extract enhances noncontact erection in rats: the role of dopamine in the paraventricular nucleus and the mesolimbic system. Neuroscience 189 : 199-206.
67. Yirmiya R. 1996. Endotoxin produces a depressive-like episode in rats. Brain Res 711: 163-174.
68. Zigmond MJ, Stricker EM. 1972. Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats. Science 177 : 1211-1214.